Unusual Options Activity Insight: DexCom
nShares of DexCom (NASDAQ:DXCM) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $494.82.
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
Dexcom Stock Jumps As Q2 Earnings Beats Street, Raises Guidance; Analysts Bump Up Target Price
Continuous glucose monitor developer Dexcom Inc (NASDAQ:DXCM) shares ticked up as second-quarter results easily topped the consensus forecast; adjusted EPS of 0.76…
Where DexCom Stands With Analysts
DexCom (NASDAQ:DXCM) has observed the following analyst ratings within the last quarter:
Last 30 Days
1 Month Ago
2 Months Ago
Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $500
Canaccord Genuity analyst Kyle Rose maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $455 to $500.
Oppenheimer Maintains Outperform on DexCom, Raises Price Target to $525
Oppenheimer analyst Steven Lichtman maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $500 to $525.
Stocks That Hit 52-Week Highs On Friday
On Friday morning, 154 companies achieved new highs for the year.
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam’s Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)